Skip to main content

Table 3 Analysis of CD4+ T cells, CD8+ T cells and B cells subpopulations by flow cytometry

From: Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy

Lymphocyte subpopulations

Cases

Controls

p

CD4+ T cells subpopulationsa

 Naïve (%)

33.1 (15.9–44.3)

39.2 (31.4–55.7)

0.026

 Central Memory (%)

38.7 (24.4–48.6)

31.9 (24.4–40.9)

0.569

 Effector Memory (%)

18.1 (13.5–25.8)

9.8 (6.8–11.6)

0.001

 CD4+ CD28+ (%)

91.7 (85.4–97.3)

98.5 (92.8–99.2)

0.070

 CD4+ CD57+ (%)

65.1 (21.2–80.0)

38.1 (24.0–70.6)

0.215

CD8+ T cells subpopulationsb

 Naïve (%)

17.6 (8.3–27.1)

27.0 (19.8–41.1)

0.039

 Central Memory (%)

2.2 (1.4–4.4)

4.1 (2.5–7.2)

0.079

 Effector Memory (%)

34.0 (21.1–44.1)

31.8 (21.4–37.8)

0.535

 CD8+ 45RA+ (%)

60.9 (40.0–67.6)

63.6 (46.8–73.8)

0.717

 CD8+ CD28+ (%)

83.5 (57.2–91.7)

83.7 (57.1–93.2)

0.959

 CD8+ CD57 (%)

32.6 (18.2–40.1)

20.2 (14.3–26.5)

0.088

 CD8+ CD45RA+ CD28- (%)

16.8 (9.0–40.4)

18.45 (7.5–34.4)

0.605

 CD8+ CD45RA+ CD57+ (%)

41.6 (22.2–55.6)

24.7 (10.1–32.2)

0.015

B cells subpopulationsc

 Naïve (%)

75.9 (64.3–87.5)

71.0 (65.3–77.8)

0.587

 Memory (%)

18.2 (8.0–23.4)

27.8 (22.3–31.8)

0.017

 Plasmablasts (%)

0.5 (0.1–1.1)

0.2 (0.1–0.4)

0.163

  1. a CD4+ subpopulations are reported as % of CD4+ cells. Values in cases and controls are reported as median (IQR)
  2. b CD8+ subpopulations are reported as % of CD8+ cells. Values in cases and controls are reported as median (IQR)
  3. c CD19+ subpopulations are reported as % of CD19+ cells. Values in cases and controls are reported as median (IQR)